Cargando…

Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model

The abnormal fetal environment exerts long-term effects on skeletal muscle, and fetal growth restriction (FGR) is associated with insulin resistance in adulthood. In this study, we examined insulin resistance in early adulthood and insulin signaling in skeletal muscle using a novel FGR rat model. Am...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokita, Kazuhide, Shoji, Hiromichi, Arai, Yoshiteru, Awata, Kentaro, Santosa, Irena, Murano, Yayoi, Shimizu, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844385/
https://www.ncbi.nlm.nih.gov/pubmed/36649006
http://dx.doi.org/10.3390/pediatric15010006
_version_ 1784870643257311232
author Tokita, Kazuhide
Shoji, Hiromichi
Arai, Yoshiteru
Awata, Kentaro
Santosa, Irena
Murano, Yayoi
Shimizu, Toshiaki
author_facet Tokita, Kazuhide
Shoji, Hiromichi
Arai, Yoshiteru
Awata, Kentaro
Santosa, Irena
Murano, Yayoi
Shimizu, Toshiaki
author_sort Tokita, Kazuhide
collection PubMed
description The abnormal fetal environment exerts long-term effects on skeletal muscle, and fetal growth restriction (FGR) is associated with insulin resistance in adulthood. In this study, we examined insulin resistance in early adulthood and insulin signaling in skeletal muscle using a novel FGR rat model. Ameroid constrictors (AC) were placed on the bilateral uterine and ovarian arteries of rats on day 17 of gestation; placebo surgery was performed on the control group. We measured body weight at birth, 4, 8, and 12 weeks of age and performed oral glucose tolerance tests at 8 and 12 weeks. Rats were dissected at 12 weeks of age. We examined the mRNA and protein expression of insulin signaling pathway molecules in skeletal muscle. FGR rats had a significantly lower birth weight than control rats (p = 0.002). At 12 weeks of age, the incremental area under the curve of blood glucose was significantly higher, and GLUT4 mRNA and protein expression in soleus muscle was significantly lower in the FGR group than in the control group. Reduced placental blood flow in the AC-attached FGR group caused insulin resistance and altered insulin signaling in skeletal muscles. Therefore, FGR causes skeletal muscle insulin resistance in early adulthood.
format Online
Article
Text
id pubmed-9844385
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98443852023-01-18 Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model Tokita, Kazuhide Shoji, Hiromichi Arai, Yoshiteru Awata, Kentaro Santosa, Irena Murano, Yayoi Shimizu, Toshiaki Pediatr Rep Article The abnormal fetal environment exerts long-term effects on skeletal muscle, and fetal growth restriction (FGR) is associated with insulin resistance in adulthood. In this study, we examined insulin resistance in early adulthood and insulin signaling in skeletal muscle using a novel FGR rat model. Ameroid constrictors (AC) were placed on the bilateral uterine and ovarian arteries of rats on day 17 of gestation; placebo surgery was performed on the control group. We measured body weight at birth, 4, 8, and 12 weeks of age and performed oral glucose tolerance tests at 8 and 12 weeks. Rats were dissected at 12 weeks of age. We examined the mRNA and protein expression of insulin signaling pathway molecules in skeletal muscle. FGR rats had a significantly lower birth weight than control rats (p = 0.002). At 12 weeks of age, the incremental area under the curve of blood glucose was significantly higher, and GLUT4 mRNA and protein expression in soleus muscle was significantly lower in the FGR group than in the control group. Reduced placental blood flow in the AC-attached FGR group caused insulin resistance and altered insulin signaling in skeletal muscles. Therefore, FGR causes skeletal muscle insulin resistance in early adulthood. MDPI 2023-01-16 /pmc/articles/PMC9844385/ /pubmed/36649006 http://dx.doi.org/10.3390/pediatric15010006 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tokita, Kazuhide
Shoji, Hiromichi
Arai, Yoshiteru
Awata, Kentaro
Santosa, Irena
Murano, Yayoi
Shimizu, Toshiaki
Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
title Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
title_full Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
title_fullStr Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
title_full_unstemmed Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
title_short Skeletal Muscle Insulin Resistance in a Novel Fetal Growth Restriction Model
title_sort skeletal muscle insulin resistance in a novel fetal growth restriction model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844385/
https://www.ncbi.nlm.nih.gov/pubmed/36649006
http://dx.doi.org/10.3390/pediatric15010006
work_keys_str_mv AT tokitakazuhide skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel
AT shojihiromichi skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel
AT araiyoshiteru skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel
AT awatakentaro skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel
AT santosairena skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel
AT muranoyayoi skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel
AT shimizutoshiaki skeletalmuscleinsulinresistanceinanovelfetalgrowthrestrictionmodel